No, I don’t think it’s because of a licensing deal. I think Jay has told us very clearly that he wants us to be perceived as an oncology company and they needed to clean up the website so if MERCK or AstraZeneca or GSK look at our website, they see we are 100% focused on Onc, but if they dig deeper, they can look at Our press releases and pipeline and see how rich it actually is and the diversity of disease states that LL can participate in.

So MERCK sees the poster and gets wind of it and important people at that company open up the CYDY website and see everything there talks about cancer because that’s why they opened the webpage in the first place. There’s nobody opening it for HIV right now. There’s nobody opening it for MASH right now. They want the first look to be cancer and they did a hell of a job.